What is a site management organization (SMO) in clinical research?
A site management organization (SMO) is a company that manages the day-to-day running of clinical trials at hospitals and investigator sites. It supplies trained clinical research coordinators, handles ethics committee paperwork and site documentation, and helps sites meet the protocol, GCP and national regulations — so investigators can focus on patient care and medical decisions.
What is the difference between an SMO and a CRO?
A contract research organization (CRO) works for the sponsor and manages a trial across all its sites — project management, monitoring, data management, biostatistics and regulatory submissions to the drug regulator. An SMO works at the site: it supports the investigator and site team with coordination, documentation and ethics committee work. Many trials use both — the CRO’s monitors visit sites whose daily operations an SMO runs.
What does a clinical research coordinator (CRC) do?
A CRC runs the study at site level under the principal investigator’s delegation: scheduling participant visits, supporting the informed consent process, maintaining source documents and the investigator site file, entering data into CRFs or EDC and resolving queries, tracking investigational product, and preparing for monitoring visits and audits. Medical decisions stay with the investigator.
Is CTRI registration mandatory for clinical trials in India?
Yes. A clinical trial must be registered on the Clinical Trials Registry – India (CTRI), maintained by ICMR, before the first participant is enrolled (NDCT Rules 2019, Rule 25(v)); registration has been mandatory since 15 June 2009. Ethics committees and sponsors check the CTRI number, so sites should not begin screening without it.
What approvals are needed before enrolling the first participant in India?
Three: permission from the Central Licensing Authority (CDSCO) to conduct the trial, approval from an ethics committee registered under Rule 8 of the NDCT Rules for that site (Rule 19), and CTRI registration (Rule 25(v)). The licensing authority must also be informed of the ethics committee approval within 15 working days (Rule 25(iv)).
Can a hospital without its own ethics committee take part in a clinical trial?
Yes. Under Rule 25(ii) of the NDCT Rules 2019, a site without its own ethics committee may use the committee of another trial site or an independent ethics committee, provided that committee is registered and located in the same city or within 50 km of the site.
When is audio-video recording of informed consent required in India?
For vulnerable participants in clinical trials of a new chemical entity or new molecular entity, the informed consent process — including how information was given and the participant’s understanding — must be audio-video recorded and kept on record. For trials of anti-HIV and anti-leprosy drugs, only an audio recording is required (NDCT Rules 2019, Third Schedule).
What is the SAE reporting timeline in India?
Under the New Drugs and Clinical Trials Rules, 2019, the investigator reports every serious adverse event to the Central Licensing Authority (CDSCO), the sponsor and the ethics committee within 24 hours of its occurrence, giving reasons if the report is late (Rule 42). A report after due analysis follows within 14 days to the licensing authority, the ethics committee chair and the head of the institution. Follow the protocol’s safety section too — sponsors often set stricter internal timelines.
Which documents are needed for an ethics committee submission in India?
A typical initial submission includes the covering letter, protocol and any amendments, investigator’s brochure, participant information sheet and informed consent form in English and the local languages used at site, case report form, investigator CVs and GCP training records, investigator undertaking, site and insurance or compensation documents, the regulatory permission or its status, and the clinical trial agreement or budget. Each committee publishes its own checklist and format, so we work from the specific committee’s SOPs.
Who is responsible for a trial at site — the SMO or the investigator?
The principal investigator. Coordinators from an SMO work under the investigator’s signed delegation log, and delegating a task does not transfer responsibility for it. Medical decisions, eligibility confirmation and participant safety stay with the investigator; the SMO makes sure the work around them is done, documented and on time.
Do hospitals and investigators need an SMO to run clinical trials?
Not always. Large hospitals with an established clinical research department often run trials with in-house coordinators. An SMO is most useful when a site is new to industry trials, when a busy investigator lacks trained coordinators, or when a sponsor needs consistent, GCP-ready operations across sites quickly.
Which SMO services does iLearn CRI provide?
iLearn CRI provides three SMO service lines from its Wakad, Pune base: clinical trial feasibility and site selection; clinical research coordinator (CRC) staffing and site operations from start-up to close-out; and regulatory and ethics committee submissions, including CTRI registration support and SAE reporting coordination. Services can be taken individually or together.
How are SMO services priced?
SMO work is quoted per study, based on scope: the number of sites, visits and participants, whether coordinators are dedicated or shared, study duration, and which submissions are needed. Share the synopsis or key parameters (no confidential protocol detail before an NDA) and we will scope it with you.